Detalhe da pesquisa
1.
PreHevbrio: the first approved 3-antigen hepatitis B vaccine.
Expert Rev Vaccines
; 22(1): 1041-1054, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37877189
2.
Assessment of immunogenicity and safety across two manufacturing lots of a 3-antigen hepatitis B vaccine, Sci-B-Vac®, compared with Engerix-B® in healthy Asian adults: A phase 3 randomized clinical trial.
Vaccine
; 39(29): 3892-3899, 2021 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34116873
3.
Rapid and high seroprotection rates achieved with a tri-antigenic Hepatitis B vaccine in healthy young adults: Results from a Phase IV study.
Vaccine
; 39(8): 1328-1332, 2021 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33451780
4.
Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine: A Phase 3 Randomized Clinical Trial.
JAMA Netw Open
; 4(10): e2128652, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34636914
5.
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial.
Lancet Infect Dis
; 21(9): 1271-1281, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33989539